These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis. Jo WR, Kim SH, Kim KW, Suh CH, Kim JK, Kim H, Lee JG, Oh WY, Choi SE, Pyo J. Eur J Radiol; 2017 Oct; 95():56-65. PubMed ID: 28987699 [Abstract] [Full Text] [Related]
8. Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease. Lai S, Mangiulli M, Perrotta AM, Di Lazzaro Giraldi G, Testorio M, Rosato E, Cianci R, Gigante A. Kidney Blood Press Res; 2019 Oct; 44(5):1142-1148. PubMed ID: 31550720 [Abstract] [Full Text] [Related]
9. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis. Raina R, Lou L, Berger B, Vogt B, Do AS, Cunningham R, Vasavada P, Herrmann K, Dell K, Simonson M. BMC Nephrol; 2016 Feb 29; 17():22. PubMed ID: 26923419 [Abstract] [Full Text] [Related]
10. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease. Coban M, Inci A. Int Urol Nephrol; 2018 Jul 29; 50(7):1293-1300. PubMed ID: 29654395 [Abstract] [Full Text] [Related]
12. MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study. Lai S, Mastroluca D, Perrotta AM, Muscaritoli M, Lucciola S, Felli MP, Izzo P, Rotondi S, Izzo S, Tartaglione L, Belli R, Ramaccini C, Izzo L, De Intinis C, Panebianco V, Mazzaferro S. J Nephrol; 2024 Jul 05. PubMed ID: 38969871 [Abstract] [Full Text] [Related]
13. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease. Ozkurt S, Dogan I, Ozcan O, Fidan N, Bozaci I, Yilmaz B, Bilgin M. Int Urol Nephrol; 2019 Jul 05; 51(7):1191-1197. PubMed ID: 31012038 [Abstract] [Full Text] [Related]
17. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function. Boertien WE, Meijer E, de Jong PE, ter Horst GJ, Renken RJ, van der Jagt EJ, Kappert P, Ouyang J, Engels GE, van Oeveren W, Struck J, Czerwiec FS, Oberdhan D, Krasa HB, Gansevoort RT. Am J Kidney Dis; 2015 Jun 05; 65(6):833-41. PubMed ID: 25600953 [Abstract] [Full Text] [Related]
18. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade? Brosnahan GM, Abebe KZ, Moore CG, Bae KT, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Rahbari-Oskoui FF, Steinman TI, Torres VE, The Halt Pkd Investigators. Curr Hypertens Rev; 2018 Jun 05; 14(1):39-47. PubMed ID: 29564978 [Abstract] [Full Text] [Related]
19. Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease. Suwabe T, Ubara Y, Oba Y, Mizuno H, Ikuma D, Yamanouchi M, Sekine A, Tanaka K, Hasegawa E, Hoshino J, Sawa N. J Nephrol; 2023 May 05; 36(4):999-1010. PubMed ID: 36753000 [Abstract] [Full Text] [Related]